. . . "House"@en . . "Biomaterials Access Assurance Act of 1998 is a United States federal statute establishing liability exemptions for biomaterial suppliers selling chemical components and raw materials utilized in implantable devices for human recipients. The United States federal legislation sets forth rules limiting litigation costs or unwarranted lawsuits for biomaterial suppliers excluded from the design, production, and testing of implantable devices demonstrated as effective and safe to include adequate product warnings."@en . "105"^^ . . "Passed without objection"@en . . . . "21"^^ . . . . . . . "Passed unanimous consent"@en . . . . . . "1997-02-27"^^ . . "Senate"@en . . "George Gekas"@en . . "979122966"^^ . . "1998-07-30"^^ . . . "\u00A7 1601 et seq."@en . . . . "An Act to establish rules governing product liability actions against raw materials and bulk component suppliers to medical device manufacturers, and for other purposes."@en . . . "Biomaterials Access Assurance Act of 1998"@en . . "Biomaterials Access Assurance Act of 1998"@en . . . . . . . . . . . . . . . . . . . "William J. Clinton"@en . . . "1998-08-13"^^ . . "Biomaterials Access Assurance Act of 1998 is a United States federal statute establishing liability exemptions for biomaterial suppliers selling chemical components and raw materials utilized in implantable devices for human recipients. The United States federal legislation sets forth rules limiting litigation costs or unwarranted lawsuits for biomaterial suppliers excluded from the design, production, and testing of implantable devices demonstrated as effective and safe to include adequate product warnings. The H.R. 872 bill was passed by the 105th United States Congressional session and enacted into law by the 42nd President of the United States Bill Clinton on August 13, 1998."@en . . "Biomaterials Access Assurance Act of 1997"@en . . "House"@en . . "105"^^ . "6956"^^ . . . "51516530"^^ . . "1998-08-13"^^ .